1462
Y. JIKUMARU et al.
growth.7) However, no extensive studies on the bio-
logical activities of JA derivatives have been reported.
dissolved in 0.1 M aqueous HCl (50 ml) and extracted
with ethyl acetate (50 ml, three times). The combined
ethyl acetate layers were dried over anhydrous sodium
sulfate and concentrated in vacuo. The residue was
chromatographed in a column of silica gel (10 g of
Wako C-300 gel), using a mixture of ethyl acetate–
acetic acid (99:1, v/v) as an eluent, to give the [(ꢁ)-
JA]–L-amino acid conjugate. The reaction of the [(ꢁ)-
JA]–N-hydroxysuccinimide ester with L-alanine, L-va-
line, L-leucine and L-isoleucine afforded a mixture of
diastereoisomeric N-jasmonoyl–L-amino acid conju-
gates, [(þ)-JA–L-amino acid and (ꢀ)-JA–L-amino acid].
The respective diastereomers were separated by high-
performance liquid chromatography (HPLC) in an ODS
4253D column (250 mm long, 10 mm internal diameter;
Senshu Scientific, Inc., Tokyo Japan), elution being
performed with 42.5% (JA–alanine), 50% (JA–valine),
or 57.5% (JA–leucine and JA–isoleucine) aqueous
MeOH containing 0.1% acetic acid at a flow rate of
3 ml minꢀ1. The products were monitored at 210 nm,
their retention times being as follows: [(þ)-JA]–L-
alanine, 28.0 min; [(ꢀ)-JA]–L-alanine, 34.5 min; [(þ)-
JA]–L-valine, 28.8 min; [(ꢀ)-JA]–L-valine, 39.2 min;
[(þ)-JA]–L-leucine, 20.0 min; [(ꢀ)-JA]–L-leucine, 25.3
min; [(þ)-JA]–L-isoleucine, 19.9 min; and [(ꢀ)-JA]–L-
isoleucine, 24.8 min. The stereochemistry of the JA–L-
amino acid conjugates was determined by analyzing the
CD data shown next. The [(þ)-JA]– and [(ꢀ)-JA]–L-
amino acid conjugates showed positive and negative
Cotton effects, respectively.3) The yields and analytical
data for the reaction products were as follows. [(ꢁ)-JA]–
glycine (182 mg, 0.45 mmol, 69% yield): 1H-NMR
(CDCl3, 300 MHz) ꢁ: 6.49 (1H, m), 5.49 (1H, m), 5.30
(1H, m), 4.10 (2H, d, J ¼ 3:9 Hz), 0.95 (3H, t,
J ¼ 7:5 Hz); MS (API 3000) m=z: 266.1 ½M ꢀ Hꢂꢀ.
[(ꢁ)-JA]–ꢀ-alanine (132 mg, 0.31 mmol, 47% yield):
1H-NMR (CDCl3, 300 MHz) ꢁ: 5.49 (1H, m), 5.30 (1H,
m), 3.49 (2H, d, J ¼ 3:6 Hz), 1.59 (3H, t, J ¼ 7:5 Hz)
0.95 (3H, t, J ¼ 7:5 Hz); MS (API 3000) m=z: 280.4
½M ꢀ Hꢂꢀ. [(þ)-JA]–L-alanine (155 mg, 0.36 mmol,
Materials and Methods
Instruments. NMR spectra were determined by using
tetramethylsilane as an internal standard with an AC-P
300 spectrometer (300 MHz, Bruker). Mass spectra of
the synthesized compounds were determined with an
API 3000 mass detector (Applied Biosystems Instru-
ments, Foster City, CA, USA), a JMS SX 102 EI MS
detector (JEOL, Tokyo, Japan), or a Voyager DE-STR
MALDI-TOF mass detector (Applied Biosystems In-
struments). Circular dichroism (CD) spectra of the
synthesized compounds were determined with a J-720
spectropolarimeter (JASCO, Tokyo, Japan).
Preparation of (ꢁ)-JA. To a solution of (ꢁ)-methyl
jasmonate (JA-Me; 5.2 g, 24 mmol) in methanol
(MeOH; 50 ml), a 5 M KOH aqueous solution (7.5 ml)
was added while stirring. Stirring was continued at room
temperature for 8 h, before the reaction mixture was
neutralized with 6 M aqueous HCl and concentrated in
vacuo. The residue was dissolved in H2O (50 ml), and
the solution adjusted to pH 2–3 with 6 M aqueous HCl,
before being extracted with ethyl acetate (50 ml, 3
times). The combined organic layers were dried over
anhydrous sodium sulfate and concentrated in vacuo.
The residue was chromatographed in a column of silica
gel (150 g of Wako C-300 gel; Wako Pure Chemical
Industries Ltd., Tokyo, Japan), using a mixture of n-
hexane–ethyl acetate–acetic acid (14:6:1, v/v/v) as an
eluent, to give (ꢁ)-JA (3.8 g, 18 mmol, 75% yield).
Preparation of a (ꢁ)-JA–N-hydroxysuccinimide ester.
To a mixture of (ꢁ)-JA (1 g, 4.8 mmol) in acetonitrile
(MeCN; 10 ml) and N-hydroxysuccinimide (1.5 g,
13 mmol) in N,N0-dimethylformamide (DMF; 7.5 ml),
dicyclohexylcarbodiimide (DCC; 1.25 g, 6.1 mmol) in
MeCN (5 ml) was added while stirring. Stirring was
continued at room temperature for 48 h, before water
(20 ml) was added to decompose the excess DCC, and
the reaction mixture was filtered to remove the dicyclo-
hexylurea. The filtrate was concentrated in vacuo and
purified in a column of silica gel (100 g of Wako C-300
gel), using a mixture of n-hexane–ethyl acetate (1:3,
v/v) as an eluent, to give the [(ꢁ)-JA]–N-hydroxy-
succinimide ester (1.2 g, 3.9 mmol, 81% yield).
1
55% yield): H-NMR (CDCl3, 300 MHz) ꢁ: 6.18 (1H,
m), 5.48 (1H, m), 5.29 (1H, m), 4.63 (1H, m), 1.59 (3H,
d, J ¼ 7:9 Hz), 0.95 (3H, t, J ¼ 7:5 Hz); MS (API 3000)
m=z: 280.4 ½M ꢀ Hꢂꢀ; CD (c 0.0281, MeOH) ꢀ"max
(nm): þ2:28 (296). [(ꢀ)-JA]–L-alanine (169 mg, 0.39
1
mmol, 60% yield): H-NMR (CDCl3, 300 MHz) ꢁ: 6.35
(1H, m), 5.46 (1H, m), 5.28 (1H, m), 4.63 (1H, m), 1.59
(3H, d, J ¼ 7:9 Hz), 0.95 (3H, t, J ¼ 7:5 Hz); MS (API
3000) m=z: 280.4 ½M ꢀ Hꢂꢀ; CD (c 0.0281, MeOH)
ꢀ"max (nm): ꢀ1:78 (299). [(þ)-JA]–L-valine (223 mg,
General procedure for preparing JA–L-amino acid
conjugates. [(ꢁ)-JA]–N-hydroxysuccinimide ester (200
mg, 0.65 mmol) in MeCN (10 ml) was mixed with a
solution of 1 mmol amino acid (glycine, ꢀ-alanine, L-
alanine, L-valine, L-leucine, or L-isoleucine) in H2O
(10 ml). To this mixture, triethylamine (1 ml, 8.5 mmol)
was added while stirring. Stirring was continued over-
night at room temperature, the resulting reaction mixture
then being concentrated in vacuo. The concentrate was
1
0.47 mmol, 72% yield): H-NMR (CDCl3, 300 MHz) ꢁ:
6.10 (1H, m), 5.47 (1H, m), 5.26 (1H, m), 4.62 (1H, m),
1.60 (1H, m), 0.88–1.09 (9H); MS (API 3000) m=z:
308.4 ½M ꢀ Hꢂꢀ; CD (c 0.0309, MeOH) ꢀ"max (nm):
þ2:39 (298). [(ꢀ)-JA]–L-valine (158 mg, 0.33 mmol,
1
51% yield): H-NMR (CDCl3, 300 MHz) ꢁ: 6.08 (1H,
m), 5.51 (1H, m), 5.40 (1H, m), 4.63 (1H, m), 1.63 (1H,
m), 0.91–1.07 (9H); MS (API 3000) m=z: 308.4